RAMP: Registry of Anesthesia and Perioperative Medicine

Sponsor
Clinica Alemana de Santiago (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05869578
Collaborator
(none)
10,000
1
259.1
38.6

Study Details

Study Description

Brief Summary

To assess mortality and morbidity associated to anesthesia interventions

Detailed Description

Currently evidence-based medicine is one of the most important tools guiding our medical practice. Part of this evidence has been generated from clinical records, which has allowed access to large databases from which relevant information has been obtained for perioperative risk stratification, searching for complications, having specific information on procedures, among others.

A clear example, especially useful daily in anesthesia work, is the NSQIP score, a tool that allows calculating perioperative risk according to the conditions of the patient and the surgery. NSQIP score is considered to make decisions in both the American and the European guidelines for preoperative evaluation for surgery.

Latin-American or Chilean databases are not available at the present time. Chile lacks of population perioperative databases, methodology and practice of medicine outcomes records, thus making necessary the generation of a retrospective/prospective registry.

The investigators expect that this registry will allow the collection of perioperative information appropriate to characterize the Chilean population, observe its evolution, and detect risk factors. Moreover, this registry will grant the investigators the means to design new research studies that may allow them to gather medical evidence of superior quality, thus benefiting patients with the best and safest interventions and procedures.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
10000 participants
Observational Model:
Cohort
Time Perspective:
Other
Official Title:
Registry of Patients Subjected to the Perioperative Care of the Anesthesia Service of Clinica Alemana of Santiago Chile
Anticipated Study Start Date :
Jun 1, 2023
Anticipated Primary Completion Date :
Jan 1, 2035
Anticipated Study Completion Date :
Jan 1, 2045

Outcome Measures

Primary Outcome Measures

  1. All-cause mortality rate in the postoperative period [30 days]

    Posoperative mortality of individuals exposed to any anesthesia related intervention or event

  2. All-cause mortality rate in the posoperative period [one year]

    Posoperative mortality of individuals exposed to any anesthesia related intervention or event

  3. Number of patients presenting a complication in the posoperative period [30 days]

    Perioperative morbidity of individuals exposed to any anesthesia related intervention or event.

  4. Number of patients who needed rehospitalization in the posoperative period [7 days after primary discharge]

    Posoperative rehospitalization rate of individuals exposed to any anesthesia related intervention or event, after primary discharge

  5. Number of deaths in the postoperative period after readmission [up to 30 days]

    In-hospital mortality of patients that were readmitted after primary discharge

Secondary Outcome Measures

  1. Change from baseline in pain, as measured by the visual analog scale (VAS) [Baseline pre-intervention VAS, postoperative/intervention 1 hour VAS, postoperative/intervention 24 hour VAS]

    Scores are measured on a 10-point VAS. The VAS ranges from 0 to 10 with 0 indicating no pain, and higher scores indicating greater pain.

  2. Number of patients that develops postoperative acute kidney injury, as measured by Kidney Disease Improving Global Outcomes (KIDGO)-2012 serum creatinine criteria [7 and 30 days]

    Criteria for developing acute kidney injury are: Increase in serum creatinin by ≽0.3 mg/dl (≽26.5lmol/l) within 48hours; or Increase in serum creatinine ≽1.5 times baseline, which is known or presumed to have occurred within the prior 7 days; or Urine volume < 0.5ml/kg/h for 6hours.

  3. Number of patients that develops postoperative Major Acute Cardiac Events (MACE), as defined by the American Heart Association [7 and 30 days]

    Criteria for MACE are the development of any of the following conditions Non-fatal stroke Non-fatal myocardial infarction Cardiovascular death

  4. Number of patients that develop posoperative chronic pain as measured by visual analog scale [3, 6, and 12 months]

    Scores are measured on a 10-point VAS. The VAS ranges from 0 to 10 with 0 indicating no pain, and higher scores indicating greater pain.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • All individuals

  • Individuals agreeing to participate in the study by signing a consent

Exclusion Criteria:
  • The subjects who had insufficient data in their files

Contacts and Locations

Locations

Site City State Country Postal Code
1 Clinica Alemana de Santiago Santiago Region Metropolitana De Santiago Chile 7591538

Sponsors and Collaborators

  • Clinica Alemana de Santiago

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Clinica Alemana de Santiago
ClinicalTrials.gov Identifier:
NCT05869578
Other Study ID Numbers:
  • UIEC1166
First Posted:
May 22, 2023
Last Update Posted:
May 22, 2023
Last Verified:
May 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 22, 2023